Lexaria Bioscience (LEXX) jumped 12% after a $2.6M Australian R&D tax rebate boosted cash runway without dilution.

Brian Stutland, Equity Armor Investments portfolio manager, joins 'Power Lunch' to discuss Palo Alto's upcoming earnings ...

Washington just handed 100-year control of the world's largest proven oil reserves to a private company most investors have ...

Nvidia just anchored a $35 billion compute deal where it supplies the chips, backs the cloud tenant, and holds the lease on ...

Christopher Mayer, CEO of Longbridge Financial, has been named a 2026 HousingWire Vanguard Editor’s Choice Award winner, ...

BakerHostetler has added Daniel Passage as of counsel in its Los Angeles office, where he joins the firm’s Business Practice Group and Debt Finance team.

Over the past 30+ go-to-market engagements enabled by Habenae, there's been a stark trend: ARR growth in the first quarter is ...

Nominations for Markets Media Group’s 2026 European Women in Finance Awards will close on September 8. The seventh annual ...

Using your home equity may not be the best retirement plan. Here's why retirees should consider selling costs, moving costs, ...

US stocks declined as 10-year Treasury yields hit 4.75%, oil prices topped $92, and geopolitical concerns pressured markets.

Swiss Finance Minister Karin Keller-Sutter slammed lawmakers for easing UBS capital rules, calling the 50% CET1 compromise inadequate for ...